Home > Insider Trading > Filing (0001104659-13-085977)

Filing Details

Accession Number:: 0001104659-13-085977
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-20 12:54:15
Reporting Period:: 2013-09-30

Filing Date:: 2013-11-20
Accepted Time:: 2013-11-20 12:54:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410939	Ophthotech Corp.	OPHT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1252522	Nicholas Galakatos	C/O Clarus Ventures, Llc, 101 Main Street, Suite 1210 Cambridge MA 02142		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-30	2,500	$22.00	2,500	No	4	P	Direct
Common Stock	Acquisiton	2013-09-30	2,500	$22.00	2,500	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,054,744	Indirect	See Footnote

Footnotes

These shares are held by AAG Peakham Trust LLC. Dr. Galakatos is a manager of AAG Peakham Trust LLC.
Reflects 3,054,744 shares of Common Stock held of record by Clarus Lifesciences II, L.P. ("Clarus"). Clarus Ventures II GP, L.P. (the "GPLP"), as the sole general partner of Clarus, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLP disclaims beneficial ownership of all shares held of record by Clarus in which the GPLP does not have an actual pecuniary interest. Clarus Ventures II, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLLC disclaims beneficial ownership of all shares held of record by Clarus in which the GPLLC does not have an actual pecuniary interest.
Dr. Galakatos, together with other individuals identified in filings made by Clarus, each as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Clarus. Dr. Galakatos disclaims beneficial ownership of all shares held of record by Clarus in which he does not have an actual pecuniary interest. The 3,054,744 shares of Common Stock held of record by Clarus constitute shares of Common Stock issued upon the conversion of preferred stock, including shares of preferred stock issued as accrued stock dividends, in connection with the closing of the issuer's initial public offering, which shares were previously reported on a Form 4 filed on October 2, 2013.